Single-use Bronchoscopes Market to Expand at a 23.6% CAGR, Hitting USD 3.26 Billion by 2033 | Persistence Market Research Report

The global single-use bronchoscopes market has witnessed significant growth in recent years, driven by technological advancements and increasing demand for minimally invasive procedures. The market expanded at a CAGR of 16.7% from 2018 to 2022, reaching a valuation of US$ 330.4 million in 2022. Forecasts indicate a surge in sales, with the market expected to grow at a CAGR of 23.6%, reaching a valuation of US$ 3.26 billion by 2033.

Among the various segments, COPD indication accounted for a dominant 29.5% market share in 2022. Geographically, North America led the market due to the high prevalence of respiratory diseases and favorable regulatory policies supporting the adoption of single-use medical devices.

Get a Sample PDF Brochure of the Report (Use Corporate Email ID for a Quick Response): https://www.persistencemarketresearch.com/samples/25891

Key Highlights

The market grew at a CAGR of 16.7% from 2018 to 2022.

Global valuation is projected to reach US$ 3.26 billion by 2033.

COPD indication held 29.5% of the market share in 2022.

Single-use bronchoscopes accounted for 28.2% of the global single-use endoscopes market.

The demand surge is driven by increasing lung cancer cases and the need for infection prevention.

Key players are focusing on innovation in imaging quality, maneuverability, and tool interaction.

Market Segmentation

Single-use bronchoscopes are segmented based on product type, end-user, and indications. Among these, flexible single-use bronchoscopes dominate due to their ease of use and infection control advantages over reusable bronchoscopes.

In terms of end-users, bronchoscopy suites held a 44.5% share in 2022, driven by the availability of trained medical personnel and specialized infrastructure. Additionally, COPD was the leading indication, accounting for a 29.5% market share, owing to the rising global burden of chronic respiratory diseases.

Regional Insights

North America

The United States leads the global single-use bronchoscopes market, holding a 30.2% share in 2022. Factors such as FDA recommendations favoring disposable bronchoscopes for infection control and the high incidence of lung cancer contribute to the region's dominance.

Asia-Pacific

China held a 7.9% market share in 2022, with rising geriatric populations and an increasing focus on minimally invasive procedures driving market growth. Government approvals for disposable bronchoscopes further support adoption in the region.

Market Dynamics

Market Drivers

Rising Incidence of Lung Cancer: The World Cancer Research Fund International reported over 2.2 million new lung cancer cases in 2020, fueling the demand for bronchoscopy procedures.

Increased Focus on Infection Control: The COVID-19 pandemic heightened awareness about hospital-acquired infections, prompting a shift toward disposable bronchoscopes.

Technological Advancements: Improvements in imaging quality, sterility, and maneuverability enhance the efficiency of single-use bronchoscopes.

Market Restraints

Environmental Concerns: The disposal of single-use medical devices contributes to medical waste accumulation, posing environmental challenges.

Cost Constraints: The higher per-unit cost of disposable bronchoscopes compared to reusable ones limits adoption in resource-constrained healthcare facilities.

Market Opportunities

Development of Biodegradable Bronchoscopes: The introduction of eco-friendly alternatives can mitigate environmental concerns.

Expansion in Emerging Markets: Increasing healthcare infrastructure in developing regions presents growth opportunities.

Government Support and Regulations: Favorable regulatory policies promoting single-use medical devices enhance market potential.

Reasons to Buy the Report

✔ Comprehensive analysis of market trends and growth forecasts.
✔ Detailed segmentation insights based on product type, end-user, and indication.
✔ Regional analysis highlighting key growth areas.
✔ Competitive landscape featuring key players and recent developments.
✔ Data-backed insights into market drivers, restraints, and opportunities.

Company Insights

Leading companies in the market are investing in innovation and expanding their product portfolios. Key players include Olympus Corporation, Ambu A/S, Boston Scientific Corporation, Karl Storz, and Fujifilm Holdings Corporation.

Recent Developments

Olympus Corporation received clearance for its H-SteriScopeTM single-use bronchoscopes, designed for advanced diagnostic and therapeutic procedures.

Ambu A/S secured FDA approval for the aScopeTM 5 Broncho family of sterile, single-use bronchoscopes, enhancing market penetration in the U.S.

The global single-use bronchoscopes market is set for remarkable growth, fueled by technological advancements and the increasing demand for infection control solutions. While environmental concerns remain a challenge, ongoing innovations in biodegradable materials and favorable regulatory support are expected to drive long-term market expansion.

Contact Us:

Persistence Market Research
G04 Golden Mile House, Clayponds Lane
Brentford, London, TW8 0GU UK
USA Phone: +1 646-878-6329
UK Phone: +44 203-837-5656
Email: sales@persistencemarketresearch.com
Web: https://www.persistencemarketresearch.com

About Persistence Market Research:

At Persistence Market Research, we specialize in creating research studies that serve as strategic tools for driving business growth. Established as a proprietary firm in 2012, we have evolved into a registered company in England and Wales in 2023 under the name Persistence Research & Consultancy Services Ltd. With a solid foundation, we have completed over 3600 custom and syndicate market research projects, and delivered more than 2700 projects for other leading market research companies' clients.

Our approach combines traditional market research methods with modern tools to offer comprehensive research solutions. With a decade of experience, we pride ourselves on deriving actionable insights from data to help businesses stay ahead of the competition. Our client base spans multinational corporations, leading consulting firms, investment funds, and government departments. A significant portion of our sales comes from repeat clients, a testament to the value and trust we've built over the years.

This release was published on openPR.